H1 Our client, a top 25 Global Pharma company, needed to better understand the top global key opinion leaders in pulmonary disease and oncology. They also needed to identify related second and third level rising stars to ensure continued adoption and engagement at top institutions. H1 uncovered the top 50 leaders across 12 countries, identifying an additional 78 rising stars related to those top HCPs.